#Germany #Munich #Sequencing #Novogene #X Plus

Novogene Europe Expands Sequencing Capabilities with Fifth NovaSeq X Plus System

In a significant move to advance genomic research, Novogene Europe has recently announced the installation of its fifth Illumina NovaSeq X Plus sequencing system in Europe. This strategic enhancement is a response to the increasing demand for high-throughput sequencing across the continent, establishing Novogene as a leading genomics partner known for speed and quality in research.

Tingting Zhou, Vice President of Novogene Europe, emphasized the importance of this expansion, stating, “Investing in the NovaSeq X Plus allows us to meet the increasing needs of our clients with unmatched speed and precision. This expansion ensures we remain at the forefront of sequencing innovation, empowering researchers with superior data quality to drive scientific breakthroughs.”

The NovaSeq X Plus system is renowned for its capability to generate an astounding 16 terabases of data within a mere 48 hours. This allows for essential applications such as whole-genome sequencing, single-cell RNA analysis, and complex population studies. Researchers today are faced with increasingly challenging genomic questions that require both scale and precision. By integrating this advanced technology, Novogene Europe is equipped to support vast and ambitious research projects, ensuring rapid results without compromising data integrity or environmental responsibility.

Bas Verhoef, Senior Vice President and Head of the Europe Region at Illumina, highlighted the long-standing partnership between Illumina and Novogene, noting, “For more than a decade, Illumina and Novogene have fostered an enduring relationship as we broaden the scope of genomics. The NovaSeq X Plus, being the most rapidly adopted and utilized high-throughput sequencing platform to date, ensures that researchers have access to reliable, swift, and cost-effective next-generation sequencing services.” The recent software upgrade has already garnered enthusiasm from customers, further enhancing the capabilities of the NovaSeq X Plus.

Over the past few years, Novogene Europe has methodically integrated cutting-edge technologies into its service offerings, including genomic, transcriptomic, microbial, and single-cell sequencing. The localized deployment of these systems in European laboratories enables tailored support, all while upholding global standards of excellence.

About Novogene, it is recognized as a pioneer in applying sophisticated molecular biology technology and high-performance computing to research in the life sciences. With aspirations to maintain its position as a global leader in genomics services and solutions, Novogene boasts one of the largest sequencing capacities globally. The company's commitment to leveraging scientific knowledge and providing excellent customer service is central to helping clients achieve their research objectives in the rapidly advancing field of genomics.

In summary, the addition of the fifth NovaSeq X Plus is a pivotal step for Novogene Europe in solidifying its status as a frontrunner in genomics, committed to delivering exceptional services that meet the rigorous demands of modern research while empowering scientists to translate their visionary ideas into groundbreaking discoveries. As genomics continues to evolve, Novogene stands ready to support researchers in their quest for knowledge and innovation.